Rapport Therapeutics, Inc. (RAPP)
(Delayed Data from NSDQ)
$28.93 USD
+2.05 (7.63%)
Updated Oct 31, 2025 04:00 PM ET
After-Market: $28.90 -0.03 (-0.10%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth D Momentum D VGM
Fundamental Charts
About Dividend Yield (TTM)
Rapport Therapeutics, Inc.'s dividend yield currently sits at 0%, which is in-line with the Medical - Biomedical and Genetics industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
RAPP 28.93 +2.05(7.63%)
Will RAPP be a Portfolio Killer in November?
Zacks Investment Research is releasing its prediction for RAPP based on the 1-3 month trading system that more than doubles the S&P 500.

Zacks News for RAPP
RAPP Stock Soars 62% in a Week on Meeting Phase II Epilepsy Study Goal
RAPP: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for RAPP
Is RAPP ready to move higher? 20 Day Moving Average Support shows up after rallying 7.63%
Is RAPP preparing to trend higher? 20 Day Moving Average Support shows up after sinking 1.86%
Is RAPP set to breakout? Bollinger Band Squeeze shows up after plummeting 5.42%
Is RAPP signaling a buying opportunity? Crossed Above 20 Day Moving Average shows up after rallying 9.37%
RAPP forms 20 Day Moving Average Resistance on October 27